|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
Welcome to the troll-free, moderated message board, made up of primarily ex-IMMU shareholders.
- IMMU's status:
--It is now a fully owned subsidiary of Gilead.
For those who want to continue to follow Trodelvy’s progress and IMMU’s pipeline:
Trodelvy combined with PARP for TNBC
Phase lll Ascent trial. Halted for compelling efficacy
Rollover Study for patients who are still responding after their trial has ended
Study of IMMU-132 in HR+/HER2- MBC (TROPICs-02)
Trodelvy in TNBC (NeoSTAR). Primary end point—% of complete responses in treatment naive patients.
A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)
Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer (Trophy U-01)
Trodelvy is on the path to becoming standard of care in breast cancer. You heard it here first.
This board is moderated, meaning the moderator (me) can stop people from posting here if they violate our norms. What are "our norms"? Well, be adult, play nice about sums it up. There are three responses I encourage for keeping the discussion civil and useful when you encounter a post that annoys you. In order of preference:
1> report a ToU violation to the SI admins via the link at the bottom of each post, they're good at dealing with problems.
2> send the person who posted a private message and work it out. Privately.
3> send me a private message. Wait a couple of days before doing so please, I'll usually see the message in that time frame and act (or not).
4> stay focused and leave politics out of it, even by inference. There are numerous forums you can spend as much time expounding on your favorite "why (insert favorite hot-button) is evil", we don't need to reiterate all that here.
5> do not engage in discussions about poster's motivations, etc. First of all, it's unprovable. Second I'd rather not wade through the inevitable pointless back-and-forth over something that'll never be settled anyway.
This board provides a forum for honest, civilized and friendly conversation. It is not a vehicle for spam or hidden agendas. New posters are not only welcome but are an important way to bring additional information and insights to the board. Over the years new posters have been welcomed into the group and have helped make the board successful. However, if you’re a new poster it is especially important to be sure that material assertions, be they pro or con, are thoughtful and supportable. While all posters must abide by the TOU, leeway can and will be granted to long-time posters who have made substantive contributions to the board and whose credibility has been established.
|© 2021 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|